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Authors’ response
We thank Yalcinkaya et al. for their interest in 
our article [1]. We agree with their conclusion that 
late gadolinium enhancement during cardiovascular 
magnetic resonance (CMR) provides incremental 
information for differentiating a range of structural 
changes in conditions similar to the one discussed in 
our case report. The ability of CMR to characterize 
myocardial tissue was the main focus of our discussion.
The authors correctly mention that amyloid 
patients show differences in longitudinal relaxation 
time (T1) between subepicardium, myocardium, 
subendocardium, and blood. Whilst our patients de-
monstrated early subendocardial passage through 
the null point (during T1 mapping) similar to amy-
loid patients and generally poor nulling with diffuse 
linear midmyocardial wall hyperenhancement, the 
hyperenhancement was most apparent in the mid 
and basal inferolateral and anterolateral left ven-
tricular segments, a pattern not commonly seen 
in amyloidosis. This persuaded us to proceed to 
cardiac biopsy to conclusively establish the diag-
nosis. We also would like to point out that newer 
T1 mapping based techniques, such as modified 
look-locker inversion recovery sequences, have 
been shown to robustly estimate the extent and 
severity of diffuse interstitial fibrosis that may be 
missed by conventional late gadolinium enhan-
cement imaging. We anticipate that these newer 
sequences will be increasingly used during CMR 
examination of diffusely infiltrating pathological 
conditions, such as amyloidosis [2].
Yalcinkaya et al. indicate that tagging of the 
myocardium during CMR may be able to demon-
strate any active displacement and deformation 
of tags in regions conflicting with septal hyper-
trophy. This is correct, although we are unable to 
comment on myocardial tagging findings as it was 
not performed in our case. The complexity and 
time taken for acquisition and analysis of tagging 
has made the transition of this technique from 
a research tool into everyday use very challenging. 
We however note that with the recent availability 
of feature-tracking CMR, some of the limitations 
of myocardial tagging are easily overcome and 
the former may become an integral part of CMR 
examination to detect abnormal strain and strain 
rate patterns in amyloid patients [3].
In conclusion, we entirely agree with the 
authors that tissue characterization ability of CMR 
makes this modality first amongst the others, 
compared to other competing techniques in the 
assessment of diffusely infiltrating conditions, 
such as amyloidosis. With the availability of newer 
sequences based on T1 mapping we speculate that 
CMR will only widen this lead over other imaging 
modalities.
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